Glycosphingolipid deficiency affects functional microdomain formation in Lewis lung carcinoma cells.
In view of the increasing evidence that gangliosides in membrane microdomains or rafts are closely associated with various signal transducing molecules including Src family kinases, we compared rafts in two subclones of 3LL mouse lung carcinoma cell line, J18 and J5, characterized by high and very low GM3 ganglioside contents, respectively. Rafts were isolated from cell lysates as low density detergent-insoluble microdomains (DIM) by sucrose density gradient centrifugation. J5 and J18 cells expressed comparable amounts of Src family kinases and the majority of Src kinases in both clones were concentrated in their DIMs, suggesting that GM3 is not necessary for DIM localization of Src kinases and there is no direct interaction between Src and GM3. However, the Src kinases were eliminated from DIMs after depletion of the major neutral GSLs of J5 cells, glucosylceramide and lactosylceramide, by an inhibitor of glucosylceramide synthase (D-PDMP), indicating that GSLs in general are required for Src kinase association to DIM. J5 and the D-PDMP-treated J5 cells had very similar DIM protein profiles and moreover cholesterol and sphingomyelin in the GSL-depleted cells were enriched in DIM similar to the untreated control cells. Interestingly, the levels of tyrosine-phosphorylated DIM proteins and cell proliferation of J5 cells were much lower than those of J18 cells, suggesting that GM3 might be involved in tyrosine phosphorylation of DIM proteins required for cell growth. Thus, our data suggest that GSLs are essential for functional raft formation.
Inokuchi
J I
JI
Department of Biomembrane and Biofunctional Chemistry, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Uemura
S
S
Kabayama
K
K
Igarashi
Y
Y
D000818:Animals; D018827:Carcinoma, Lewis Lung / Q000378:metabolism*; D002455:Cell Division / Q000235:genetics; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000494:pharmacology; D005679:G(M3) Ganglioside / Q000737:chemistry / Q000378:metabolism; D005959:Glucosidases / Q000737:chemistry / Q000378:metabolism; D005964:Glucosyltransferases / Q000037:antagonists & inhibitors; D006028:Glycosphingolipids / Q000172:deficiency* / Q000378:metabolism*; D007790:Lactosylceramides / Q000737:chemistry / Q000378:metabolism; D008563:Membrane Lipids / Q000378:metabolism*; D051379:Mice; D009025:Morpholines / Q000494:pharmacology; D010766:Phosphorylation; D011506:Proteins / Q000737:chemistry / Q000378:metabolism; D014407:Tumor Cells, Cultured; D014443:Tyrosine / Q000378:metabolism; D019061:src-Family Kinases / Q000737:chemistry / Q000378:metabolism
D004791:Enzyme Inhibitors; D005679:G(M3) Ganglioside; D006028:Glycosphingolipids; D007790:Lactosylceramides; D008563:Membrane Lipids; D009025:Morpholines; D011506:Proteins; D014443:Tyrosine; C033110:RV 538; D005964:Glucosyltransferases; C023246:ceramide glucosyltransferase; D019061:src-Family Kinases; D005959:Glucosidases